MileBot Robotics receives nearly RMB100M strategic investment
MileBot Robotics received a strategic investment described as nearly RMB100 million from CSC Financial as it expands its commercial exoskeleton portfolio and brain-computer-interface rehabilitation work.
Evidence notes
- CSC Financial provided the strategic investment, with Haoguan Capital acting as exclusive financial adviser.
- MileBot’s BEAR, RELAX, 3000-STEP and MAX lines cover clinical rehabilitation, community care and everyday walking assistance.
- The company said its core products hold Class II medical-device registrations and have entered scaled commercial sales.
Company context
MileBot Robotics develops flexible-actuation exoskeletons for clinical gait rehabilitation, community care and everyday mobility. Its BEAR, RELAX, 3000-STEP and MAX product lines span adult and paediatric rehabilitation plus walking assistance.